Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.13 USD | -5.30% | +3.11% | +630.63% |
Jun. 03 | Corbus Pharmaceuticals Reaches 2-Year High After Drug Results | DJ |
Jun. 03 | Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $80 From $60, Maintains Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+630.63% | 472M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+1.14% | 22.78B | |
-11.00% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- CRBP Stock
- News Corbus Pharmaceuticals Holdings, Inc.
- Corbus Pharmaceuticals Files Mixed Shelf